share_log

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Advantech Capital II L.P.(8.5%),Advantech Capital II Connect Partnership L.P.(8.5%), etc.

康乃德生物 | SC 13G:超過5%持股股東披露文件-Advantech Capital II L.P.(8.5%),Advantech Capital II Connect Partnership L.P.(8.5%)等

2022/02/15 06:05
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息